Early biological markers of post-acute sequelae of SARS-CoV-2 infection

Nat Commun. 2024 Aug 29;15(1):7466. doi: 10.1038/s41467-024-51893-7.

Abstract

To understand the roles of acute-phase viral dynamics and host immune responses in post-acute sequelae of SARS-CoV-2 infection (PASC), we enrolled 136 participants within 5 days of their first positive SARS-CoV-2 real-time PCR test. Participants self-collected up to 21 nasal specimens within the first 28 days post-symptom onset; interviewer-administered questionnaires and blood samples were collected at enrollment, days 9, 14, 21, 28, and month 4 and 8 post-symptom onset. Defining PASC as the presence of any COVID-associated symptom at their 4-month visit, we compared viral markers (quantity and duration of nasal viral RNA load, infectious viral load, and plasma N-antigen level) and host immune markers (IL-6, IL-10, TNF-α, IFN-α, IFN-γ, MCP, IP-10, and Spike IgG) over the acute period. Compared to those who fully recovered, those reporting PASC demonstrated significantly higher maximum levels of SARS-CoV-2 RNA and N-antigen, burden of RNA and infectious viral shedding, and lower Spike-specific IgG levels within 9 days post-illness onset. No significant differences were identified among a panel of host immune markers. Our results suggest early viral dynamics and the associated host immune responses play a role in the pathogenesis of PASC, highlighting the importance of understanding early biological markers in the natural history of PASC.

MeSH terms

  • Adult
  • Aged
  • Antibodies, Viral / blood
  • Antibodies, Viral / immunology
  • Biomarkers* / blood
  • COVID-19* / blood
  • COVID-19* / immunology
  • COVID-19* / virology
  • Cytokines / blood
  • Female
  • Humans
  • Immunoglobulin G / blood
  • Immunoglobulin G / immunology
  • Male
  • Middle Aged
  • Post-Acute COVID-19 Syndrome
  • RNA, Viral* / blood
  • SARS-CoV-2* / immunology
  • SARS-CoV-2* / isolation & purification
  • Viral Load*

Substances

  • Biomarkers
  • RNA, Viral
  • Cytokines
  • Antibodies, Viral
  • Immunoglobulin G